
Overview
Dr. Orr treats each and every patient with care and compassion.
Dr. Orr is rated as an Advanced provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Malignant Mixed Mullerian Tumor, and Endometrial Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1127 Wilshire Blvd, Ste 900, Los Angeles, CA 90017
Jayaram Bharadwaj is a Hematologist Oncology specialist and an Oncologist in Anaheim, California. Dr. Bharadwaj is rated as a Distinguished provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. His top areas of expertise are Drug-Induced Thrombocytopenia, Thrombocytopenia, Agranulocytosis, and Anemia.
Los Angeles Cancer Network
The mission of The Los Angeles Cancer Network is to provide compassionate individualized treatment using the most recent proven advances in cancer care as well as education and support to our patients and their families. It is also our mission to participate in important clinical research, early detection and innovative treatment. We are proud to be at the forefront of cancer research with our associates at Southwest Oncology Group and Kenmar Research Institute. I am privileged to be able to take care of our cancer patients. Dr. Boghossian is rated as a Distinguished provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Agranulocytosis, and Chronic Familial Neutropenia.
Los Angeles Hematology-Oncology Medical Group
Anas Raowas is a Hematologist Oncology specialist and a Hematologist in Riverside, California. Dr. Raowas is rated as an Advanced provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. His top areas of expertise are Drug-Induced Thrombocytopenia, Thrombocytopenia, Anemia, and Essential Thrombocythemia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Paget Disease of the BreastDr. Orr isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AngiosarcomaDr. Orr isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Orr isAdvanced. Learn about Breast Cancer.
- Cervical CancerDr. Orr isAdvanced. Learn about Cervical Cancer.
- Childhood Iron Deficiency Anemia
- Colorectal CancerDr. Orr isAdvanced. Learn about Colorectal Cancer.
- Drug-Induced Thrombocytopenia
- Experienced
- Acute Mountain SicknessDr. Orr isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Orr isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Orr isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Orr isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Orr isExperienced. Learn about Anal Cancer.
